Alaunos Therapeutics Inc. (TCRT)
NASDAQ: TCRTHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
TCRT stock chart
Technical analysisKey statistics
All statistics- Market cap
- $2.29M
- EPS (TTM)
- -$1.76
- Dividend yield
- None
- 52-week range
- 0.72 – 4.50
- Day range
- 0.78 – 0.847
- Volume / Avg
- 89.93K / 797.20K
- Beta
- —
- Shares outstanding
- 2.93M
52-week range
TCRT stock today
Alaunos Therapeutics (TCRT) closed at $0.781 on Oct 8, down 6.70% (-$0.0561), versus the S&P 500's 0.47% decline. Trading was light, with 89.93K shares changing hands, about 11% of the average daily volume. Shares are 82.6% below their 52-week high of $4.50 and 8.5% above the 52-week low of $0.72, near the bottom of the past year's range.
Alaunos Therapeutics has posted a net loss over the last twelve months (EPS of -$1.76), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Alaunos Therapeutics
Company profileAlaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Holger Weis CPA
- Headquarters
- Fort Lauderdale, FL
- Employees
- 1
- Website
- alaunos.com
Alaunos Therapeutics peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| GNPXGenprex Inc. | 2.75 | +4.96% | $2.25M | vs TCRT |
| PPBTPurple Biotech Ltd. ADR | 1.44 | -1.37% | $2.34M | vs TCRT |
| OGENOragenics Inc. | 0.463 | -7.38% | $2.09M | vs TCRT |
| ELABPMGC Holdings Inc. | 3.13 | -2.04% | $2.53M | vs TCRT |
| SPRCSciSparc Ltd. | 4.43 | -4.53% | $2.57M | vs TCRT |
| BRTXBioRestorative Therapies Inc. | 1.89 | -15.63% | $2.61M | vs TCRT |
| VBIOValion Bio Inc. | 2.21 | +0.91% | $1.96M | vs TCRT |
| VRAXVirax Biolabs Group Limited | 1.99 | -5.69% | $2.68M | vs TCRT |
Indexes, lists and sector
Appears in lists
Alaunos Therapeutics stock FAQ
What is Alaunos Therapeutics's stock price today?
TCRT last traded at $0.781 as of Oct 8, 4:00 PM EDT, down 6.70% on the day. Prices are delayed at least 15 minutes.
Who is Alaunos Therapeutics's CEO?
Mr. Holger Weis CPA is the chief executive officer of Alaunos Therapeutics Inc., which has about 1 employees.
What is the TCRT 52-week high?
The 52-week high for TCRT is $4.50 and the 52-week low is $0.72. The stock is currently 82.6% below its high.